Cargando…

Dexamethasone/prednisone/tocilizumab: Worsening of Strongyloides infection: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546929/ http://dx.doi.org/10.1007/s40278-020-84331-0

Ejemplares similares

Dexamethasone/tocilizumab: Worsening of hepatitis E virus infection following off label use: case report
Publicado: (2022)

Dexamethasone/prednisone: Acute pancreatitis: case report
Publicado: (2021)

Methylprednisolone/prednisone: Worsening of COVID-19 pneumonia: case report
Publicado: (2021)

Dexamethasone/ivermectin: Paradoxical dissemination of Strongyloides stercoralis infection, Strongyloides hyperinfection syndrome and treatment failure: case report
Publicado: (2021)

Prednisone: Enterobacter asburiae infection and worsening of SARS‐CoV‐2 infection: case report
Publicado: (2022)

Lopinavir/ritonavir/prednisone: Knee osteonecrosis and its worsening: case report
Publicado: (2021)

Azithromycin/dexamethasone/prednisone: Lack of efficacy, off label use and rebound effect in the form of worsening of subacute thyroiditis: 3 case reports
Publicado: (2022)

Prednisone/tocilizumab: Staphylococcus aureus bacteraemia and aortic valve endocarditis : case report
Publicado: (2021)

Betamethasone/dexamethasone/prednisone: Pneumocystis jirovecii pneumonia: case report
Publicado: (2021)

Dexamethasone: Acute respiratory distress syndrome secondary to Strongyloides stercoralis infection: case report
Publicado: (2015)

Dexamethasone/methylprednisolone/tocilizumab: Candidaemia: case report
Publicado: (2021)

Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide
por: Kikuchi, Taku, et al.
Publicado: (2017)

Dexamethasone/remdesivir/tocilizumab: Various toxicities: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Invasive pulmonary aspergillosis: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy: case report
Publicado: (2022)

Dexamethasone/prednisone/sodium chloride: Nosocomial legionellosis and invasive aspergillosis: case report
Publicado: (2018)

Dexamethasone: Reactivation of Strongyloides stercoralis following off-label use: 2 case reports
Publicado: (2021)

Dexamethasone/prednisone/rituximab: Prolonged SARS-CoV-2 infection and off-label use: case report
Publicado: (2022)

Tocilizumab: Infection and worsening of pre-existing COVID-19 symptoms following off-label treatment: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Methaemoglobinaemia and off-label use: case report
Publicado: (2021)

Dexamethasone/tocilizumab: Off-label-use and lack of efficacy: case report
Publicado: (2021)

Dexamethasone: Worsening of respiratory failure following rebound effect: case report
Publicado: (2022)

Dexamethasone/prednisone/tofacitinib: COVID-19, thromboembolic episodes and off-label use: case report
Publicado: (2021)

Prednisone: COVID-19 infection: case report
Publicado: (2020)

Cyclophosphamide/prednisone: Various infections: case report
Publicado: (2021)

Dexamethasone/tocilizumab: Lack of efficacy during off label use: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Off-label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Lack of efficacy following off-label therapy: case report
Publicado: (2022)

Ceftriaxone/dexamethasone/tocilizumab: Meningitis and spesis due to streptococcus pneumoniae infection and lack of efficacy: case report
Publicado: (2022)

Prednisone: No response: case report
Publicado: (2021)

Mycophenolate/prednisone: COVID-2019 infection: case report
Publicado: (2020)

Mycophenolate-mofetil/prednisone/tacrolimus: Infections: case report
Publicado: (2020)

Adalimumab/prednisone: Mycobacterium chelonae infection: case report
Publicado: (2021)

Dexamethasone/prednisolone/tocilizumab: Gastrointestinal perforation and off-label use: 3 case reports
Publicado: (2022)

Dexamethasone/ivermectin: Strongyloides stercoralis hyperinfection syndrome and allergic reaction in the form of pruritic diffuse maculopapular rash: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Rhino-orbital mucormycosis following off-label use: 11 case reports
Publicado: (2021)

Dexamethasone/tocilizumab/tofacitinib: Lack of efficacy following off label use: 2 case reports
Publicado: (2022)

Dexamethasone/methylprednisolone/tocilizumab: Fatal disseminated mucormycosis following off-label use: case report
Publicado: (2022)

Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report
por: Murayama, Yoshiaki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_03l0heco8j4k5r3bc05uegrgef